As Chief Executive Officer of Network Partners Group (NPG), Dean Malloy is at the forefront of advancing life sciences through quality, regulatory, packaging, and labeling services. Since taking on the role in September 2022, Dean has propelled NPG’s growth, achieving a 400% revenue increase and positioning the company as a multiple-time Inc. 5000 honoree. With a dynamic and visionary leadership style, he oversees the company’s three brands—Network Partners, FlexPro, and Indeio—delivering high-impact solutions for medical device and pharmaceutical clients worldwide. Dean is also dedicated to developing future industry professionals through NPG’s Leadership Programs, fostering emerging talent in quality, regulatory affairs, and packaging.

Before his role as CEO, Dean served as Chief Operations Officer of NPG, where he executed growth strategies that drove exponential company expansion. His prior experience includes serving as Vice President of Client Services with Validant Consulting, where he led operations across multiple regions, launched an East Coast office, and expanded NPG’s pharmaceutical services. Dean holds a Bachelor of Technology in Electronics Manufacturing from the University of Limerick, Ireland, an MBA from Liverpool St John Moores University in the UK, and a PMP certification. He also holds two patents for a stent delivery device, underscoring his innovative contributions to life sciences.

As Chief Financial Officer of Network Partners Group (NPG), Mitch Blumenfeld leads the finance and accounting functions, bringing over two decades of experience in financial leadership across the life sciences and pharmaceutical sectors. Mitch’s expertise drives NPG’s strategic growth and ensures robust financial stewardship, enhancing the company’s ability to deliver consistent, high-quality support for clients worldwide. His open, collaborative approach empowers the NPG team to align financial operations with organizational goals, reinforcing a foundation of integrity and excellence that supports the company’s mission.

Before joining NPG, Mitch held CFO positions at Signant Health and PCI Pharma Services, where he oversaw financial management across multiple global facilities and played critical roles in strategic expansion and acquisitions. Mitch’s early career includes senior roles at AmerisourceBergen and World Courier, as well as a 15-year tenure with General Electric, where he gained diverse experience in the US and Europe. A graduate of GE’s Edison Engineering Program, Mitch holds a Bachelor of Science in Computer Science Engineering from Bucknell University and a Master of Science in Computer Science & Applications from Virginia Tech.

As Chief People Officer at Network Partners Group (NPG), Alyse Ellman leads the company’s talent strategy and culture initiatives, serving as the driving force behind NPG’s approach to maximizing employee potential. With a data-driven approach, Alyse crafts strategic HR solutions that support team building, enhance employee engagement, and foster a corporate culture aligned with NPG’s mission. Her leadership in the Human Resources function ensures NPG’s people strategy is tailored to the needs of a dynamic, client-focused organization, creating a workplace where employees thrive.

Prior to joining NPG, Alyse founded a successful coaching and consulting business specializing in leadership development and organizational strategy across diverse industries. She previously held roles as Vice President of Talent and Organizational Capabilities at White Lodging and led customer experience initiatives at United Airlines. With experience spanning leadership, culture, and service excellence, Alyse holds a Bachelor of Science in Business Management and coaching certifications from the International Coaching Federation and Gallup’s CliftonStrengths program.

Juli Denny is the Chief Growth Officer at Network Partners Group, where she leads global commercialization efforts. Juli has spent 25 years providing compliance services to the life science industry, ensuring tailored and customized client solutions are delivered with the highest quality consulting and staffing resources. With a focused career in the healthcare industry and business development, she helps Life Science clients find solutions that grow their business.

Prior to NPG, Juli held pivotal roles in sales and marketing for renowned organizations, including Johnson & Johnson and leading service companies in regulated industries. She has vast experience in developing strategic business units within ISO 9001 and 13485 environments, creating targeted programs in sales, quality systems, R&D, and regulatory affairs. Juli holds an MBA from Augsburg University and a BA from the University of Michigan, equipping her with the expertise to lead growth initiatives in complex, highly regulated markets.

As President of Packaging and Labeling at Network Partners Group (NPG), Karen Polkinghorne applies over 25 years of life sciences experience to deliver exceptional client support. She leads NPG’s teams in Packaging Engineering, Regulatory Affairs, Labeling, Quality, and Project Management, ensuring seamless project execution for clients. Known for her client-centered approach, Karen identifies and resolves industry gaps, enhancing outcomes for pharmaceutical packaging, labeling, and medical device leaders. Her commitment to mentorship supports NPG’s mission, empowering teams to excel in this dynamic field.

Karen’s background spans technical, entrepreneurial, and business-focused roles. She began her career in packaging engineering with Schneider and Smith & Nephew, later founding Elevation Consulting and LifePack Forum to address industry needs. Since joining Network Partners in 2016, she has expanded packaging services and launched the Apprentice Leadership Program. Karen holds a Bachelor’s in Packaging from Michigan State and an MBA in Entrepreneurship from the University of Colorado – Boulder, underscoring her dedication to advancing the field.

As President of Regulatory Affairs at Network Partners Group (NPG), Ritu Dhami leverages over 18 years of experience to lead the company’s regulatory strategy and growth. Since joining NPG in 2018, she has held progressive roles, guiding key initiatives and helping grow the Regulatory Affairs and Quality Business Units by over 300%. Known for her strategic acumen, Ritu is instrumental in navigating complex regulatory landscapes, ensuring that NPG clients achieve compliance across the US, EU, and Canada. Her approach is focused on innovation, client satisfaction, and preparing NPG for its next growth phase.

Ritu’s background includes senior regulatory roles in medical device and pharmaceutical companies such as Abbott Neuromodulation, Cantox Health Sciences, and Sanofi Pasteur. At Abbott, she led regulatory efforts for Class III PMA products, Class II 510k devices, and EU Active Implantable Medical Devices. With experience spanning regulatory submissions, agency interactions, and strategy, Ritu holds a Bachelor’s in Microbiology from the University of Guelph and a Master’s in Regulatory Affairs from Northeastern University, providing her with a strong foundation in regulatory science and industry expertise.

Niall Condon brings over 40 years of experience in biopharmaceutical operations, excelling in leadership roles that emphasize the importance of people in driving business performance. As a former SVP Global Supply Organization at Pfizer – Upjohn, Head Integrated API and OSD at Viatris, and President of Manufacturing and API Sales at Curia, he has led global teams to achieve organizational transformation, efficiency, and operational excellence. Niall’s expertise spans manufacturing leadership, M&A, and site operations turnaround, and implementing Lean/Six-Sigma-based programs, significantly improving performance and delivering substantial savings. He is known for building high-performing teams and cultures through empowerment and transparent communication. Currently, Niall’s consulting business, Niall Condon LLC, is focused on advising and supporting small businesses in the BioPharma sector as they build their brand and capabilities.

In addition to joining Network Partners Group as an Executive Advisor, Dr. Jethro Ekuta serves as Chief Regulatory & Safety Officer at Ascendis Pharma, where he heads Global Regulatory Affairs & Pharmacovigilance. Prior to joining Ascendis, Dr. Ekuta was Vice President, Head of Regulatory Science Delivery at Alexion, AstraZeneca Rare Disease (2019-2024), where he built Global Labeling, Established Products, and Advertising and Compliance Teams; served as US Regulatory Lead; and led various initiatives related to process improvement, talent development, and integrations and acquisitions. From 2018 to 2019, he served as Senior Vice President, Global Head of Regulatory, Safety and Standards at Horizon Therapeutics. Before Horizon, he held Regulatory and Pharmacovigilance roles of increasing responsibility at companies that included Johnson & Johnson, Genzyme-Sanofi, Bristol-Myers Squibb, Pfizer, and Procter & Gamble Pharmaceuticals. Prior to joining industry, Dr. Ekuta was a Staff Fellow in Clinical Pharmacology at the Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA). He completed his U.S. National Institutes of Health (NIH)-sponsored post-doctoral fellowship training in neuropharmacology and cardiovascular pharmacology at Meharry Medical College, and an FDA-sponsored post-doctoral fellowship in clinical pharmacology at Vanderbilt University Medical Center.

Dr. Ekuta holds a Doctor of Veterinary Medicine (D.V.M.) degree from Ahmadu Bello University, a Ph.D. in Pharmacology & Toxicology from the University of Mississippi, and an Executive MBA degree from Quantic School of Business and Technology. He is certified in Regulatory Affairs (RAC) and is an inaugural Fellow of the Regulatory Affairs Professionals Society (FRAPS). Dr. Ekuta has served as President, RAPS Board of Directors (2023-2024) and currently serves as Chair of the Board.

With over 24 years of experience spanning pharmaceuticals, medical devices, and consumer healthcare, Dr. Lee W. Evans brings exceptional expertise in Regulatory Affairs to the Network Partners Group team. His impressive achievements include leading groundbreaking reclassifications like the UK’s first OTC antibiotic switch and building high-performing global teams at industry giants such as Pfizer, Johnson & Johnson, and Philips.

Dr. Evans is passionate about delivering patient-centric healthcare, navigating complex regulatory landscapes, driving innovation, and fostering talent through empathetic leadership. He holds a Ph.D. in Reproductive Physiology and continues to inspire as a thought partner within the life sciences industry.

William A. Kentrup is a seasoned Quality expert in the pharmaceutical and consumer goods industries, with extensive expertise in Quality Systems, Inspection Readiness, Remediation, and Quality Risk Management.

With a career spanning over four decades, William has held senior leadership positions in renowned companies such as Takeda Pharmaceuticals, Procter & Gamble, Sandoz (Novartis), Pfizer, Wyeth, and Aventis. His roles have included overseeing global quality compliance, transforming quality systems, and leading strategic initiatives in manufacturing, digitization and automation, and supplier quality.

William holds a BS degree in Chemistry from Northern Kentucky University and has been involved in professional organizations like the Parenteral Drug Association, currently a PDA/FDA planning team member.

Mark Sydnor serves as an Executive Advisor to NPG, drawing on his deep expertise in pharmaceutical quality and project management to guide our strategic initiatives. Previously, as President of Quality & Project Management at Network Partners Group, he led NPG’s pharmaceutical-focused quality and project management efforts with a client-centered approach. He brings over 20 years of experience in program management, quality systems, and regulatory consulting, ensuring that NPG clients receive the highest level of operational and quality leadership. Mark’s expertise is instrumental in optimizing quality compliance and driving successful product development and commercialization across global markets, providing NPG’s clients with the guidance and support they need to achieve regulatory excellence.

Mark’s extensive background includes leadership roles at Pfizer, Mallinckrodt Pharmaceuticals, Hospira, and Covidien, where he honed his skills in quality assurance, operational strategy, and program management. His career in consulting spans a decade, with impactful work for over 100 clients on five continents. Mark holds a Bachelor of Science in Chemical Engineering from Virginia Tech and a Master of Business Administration in Biotechnology and Finance from North Carolina State University, both of which underscore his commitment to quality and innovation in life sciences.